The amount adds up. So the $8 billion for bilateral agreements goes to the seven companies that entered into agreements. One thing isn't clear. Are we paying for the vaccines that were licensed and distributed, or are we paying for the vaccines that were reserved?
On March 10th, 2021. See this statement in context.